Gallbladder disease
Conditions
Interventions
Group using hemostatic materials or hemostatic drugs (Intraoperative use of hemostatic materials or postoperative use of hemostatic drugs):None
No use of hemostatic materials intraopetively and no use of hemostatic drugs postoperatively (No use of hemostatic materials intraopetively and no use of hemostatic drugs postoperatively):None
Sponsors
Department of HepatobiliaryPancreatic-Splenic Surgery, Chengdu First People’s Hospital (Chengdu Integrated TCM & Western Medicine Hospital)
Eligibility
Sex/Gender
All
Age
16 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1) Patients undergoing elective laparoscopic cholecystectomy; 2) Prior to surgery, informed consent should be given to the use or non use of hemostatic materials and/or hemostatic drugs as appropriate; 3) Patients with normal preoperative coagulation function; 4) The data is complete and available for analysts.
Exclusion criteria
Exclusion criteria: 1) Patients undergoing emergency laparoscopic cholecystectomy; 2) Preoperative coagulation dysfunction or bleeding tendency requiring medication treatment; 3) Those who undergo simultaneous biliary exploration and stone removal surgery or other surgeries; 4) Laparoscopic conversion to open cholecystectomy; 5) Individuals with a history of gallbladder, biliary tract, or other upper abdominal surgeries in the past; 6) Patients with concurrent malignant lesions of the gallbladder; 7) Missing data that cannot be analyzed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative bleeding volume ;postoperative bleeding incidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall hospitalization time;postoperative hospitalization time;reoperation rate;readmission rate; | — |
Countries
China
Contacts
Public ContactLai wei
Department of HepatobiliaryPancreatic-Splenic Surgery, Chengdu First People’s Hospital (Chengdu Integrated TCM & Western Medicine Hospital)
Outcome results
None listed